chalcone has been researched along with Bone Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bahety, P; Boon, CP; Ee, PL; Lee, CY; Leow, PC; Tan, KL; Yang, T | 1 |
| Belluti, F; Bisi, A; Blasi, P; Cappadone, C; Farruggia, G; Gobbi, S; Malucelli, E; Picone, G; Rossi, M | 1 |
| Gong, Z; Su, Q; Tian, Z; Xu, B | 1 |
| Eskander, R; Guo, Y; Hoang, BH; Ji, T; Krill, LS; Lin, C; Zi, X | 1 |
| Baek, SJ; Fachin, AL; Lee, SH; Marins, M; Silva, G | 1 |
5 other study(ies) available for chalcone and Bone Cancer
| Article | Year |
|---|---|
Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway.
Topics: Antineoplastic Agents; beta Catenin; Bone Neoplasms; Cell Line, Tumor; Curcumin; HEK293 Cells; Humans; Neoplasm Invasiveness; Osteosarcoma; Wnt Signaling Pathway | 2014 |
Natural-like Chalcones with Antitumor Activity on Human MG63 Osteosarcoma Cells.
Topics: Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Humans; Osteosarcoma | 2022 |
Design and development of novel 1,2,3-triazole chalcone derivatives as potential anti-osteosarcoma agents
Topics: Adolescent; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Child; Drug Screening Assays, Antitumor; Humans; Osteosarcoma; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Triazoles | 2022 |
Flavokawain B, a kava chalcone, inhibits growth of human osteosarcoma cells through G2/M cell cycle arrest and apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Flavonoids; G2 Phase Cell Cycle Checkpoints; Gene Expression; Humans; Kava; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Osteosarcoma | 2013 |
Anti-cancer activity of trans-chalcone in osteosarcoma: Involvement of Sp1 and p53.
Topics: A549 Cells; Bone Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcone; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Osteosarcoma; Sp1 Transcription Factor; Tumor Suppressor Protein p53; Up-Regulation | 2016 |